VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Signadori Bio

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Next-Generation In Vivo Monocyte Immunotherapy

  • Biotech & therapeutics
Status
Operatingas of 2026-09-21
Business model
B2B
Headquarters
Paris, France
Founded
2025
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Born from world-class oncology research, Signadori Bio is building the next-generation in vivo monocyte immunotherapy to treat solid tumors.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy